(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Live Chart Being Loaded With Signals
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery...
Stats | |
---|---|
今日成交量 | 7.43M |
平均成交量 | 5.82M |
市值 | 5.52B |
EPS | £0.0361 ( 2023-08-31 ) |
Last Dividend | £0.0443 ( 2020-03-19 ) |
Next Dividend | £0 ( N/A ) |
P/E | 2 399.00 |
ATR14 | £0.166 (0.69%) |
音量 相关性
Abcam plc 相关性 - 货币/商品
Abcam plc 财务报表
Annual | 2022 |
营收: | £361.70M |
毛利润: | £270.50M (74.79 %) |
EPS: | £-0.0372 |
FY | 2022 |
营收: | £361.70M |
毛利润: | £270.50M (74.79 %) |
EPS: | £-0.0372 |
FY | 2021 |
营收: | £297.70M |
毛利润: | £211.80M (71.15 %) |
EPS: | £0.0780 |
Financial Reports:
No articles found.
Abcam plc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.0358 | 2014-03-19 |
Last Dividend | £0.0443 | 2020-03-19 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 13 | -- |
Total Paid Out | £0.836 | -- |
Avg. Dividend % Per Year | 0.02% | -- |
Score | 3.14 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 2.72 | |
Div. Directional Score | 6.68 | -- |
Year | Amount | Yield |
---|---|---|
2014 | £0.122 | 1.59% |
2015 | £0.124 | 1.78% |
2016 | £0.117 | 1.23% |
2017 | £0.114 | 1.26% |
2018 | £0.158 | 1.12% |
2019 | £0.157 | 1.10% |
2020 | £0.0443 | 0.24% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.000600 | 1.500 | 9.99 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.000268 | 1.200 | 9.99 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.000380 | 1.500 | -1.107 | -1.660 | [0.1 - 1] |
payoutRatioTTM | 22.73 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.354 | 0.800 | 8.23 | 6.58 | [1 - 3] |
quickRatioTTM | 0.993 | 0.800 | 8.86 | 7.09 | [0.8 - 2.5] |
cashRatioTTM | 0.418 | 1.500 | 8.79 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.211 | -1.500 | 6.48 | -9.72 | [0 - 0.6] |
interestCoverageTTM | 9.21 | 1.000 | 7.70 | 7.70 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.113 | 2.00 | 9.96 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0180 | 2.00 | 9.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.302 | -1.500 | 8.79 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.779 | 1.000 | 0.352 | 0.352 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.104 | 1.000 | 9.92 | 9.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.121 | 1.000 | -0.440 | -0.440 | [0.2 - 2] |
assetTurnoverTTM | 0.446 | 0.800 | -0.360 | -0.288 | [0.5 - 2] |
Total Score | 10.65 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 16 180 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.000380 | 2.50 | -0.712 | -1.660 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0180 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.113 | 2.00 | 9.96 | 10.00 | [0 - 30] |
payoutRatioTTM | 22.73 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -68.63 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0572 | 1.000 | -1.070 | 0 | [0.1 - 0.5] |
Total Score | 2.72 |
Abcam plc
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。